DOI: 10.14704/nq.2017.15.4.1135

A Hope-Based Group Therapy Program to Women with Multiple Sclerosis: Quality of Life

Yangjun liu

Abstract


The aim of this study was to assess the effects of a Hope-Based Group Therapy (HBGT) program on Multiple Sclerosis (MS) women's quality of life. Thirty two women with MS were assigned either a HBGT group (n = 18) or a non-HBGT group (n = 14). We used the variables physical health and mental health for indicator of perceived health and the variable hope thoughts for hope-related outcome. The HBGT program resulted in significant improvements in the quality of life of women with MS. In conclusion, this study provides evidence that HBGT can be used as an effective program for improving hope thoughts, mental health and physical health in women with MS, and could thus influence their quality of life.

Keywords


Training, Hope-Based Group Therapy, Quality Of Life, Multiple Sclerosis Disease

Full Text:

PDF

References


Agha, Yousefi Alireza, Farhad Shaghaghi, Mehdi Dehestani, and Irani Ziba Barghi. "The relationship between quality of life (QOL) and psychological capital with illness perception in ms patients." (2012): 32-45.

Baumstarck K, Boyer L, Boucekine M, Michel P, Pelletier J, Auquier P. Measuring the quality of life in patients with multiple sclerosis in clinical practice: a necessary challenge. Multiple Sclerosis International 2013; 524894: 1-8.

Bejarpas OF, Soleimani S. Psychological Features of Delinquent and Nondelinquent Male and Female Adolescent. NeuroQuantology 2017; 15(2):246-252.

Berrigan LI, Fisk JD, Patten SB, Tremlett H, Wolfson C, Warren S, Fiest KM, McKay KA, Marrie RA, Blanchard J, Elliott L. Health-related quality of life in multiple sclerosis Direct and indirect effects of comorbidity. Neurology 2016; 86(15):1417-24.

Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BV, Thompson AJ. Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity. Neurology 2014; 83(11):1022-4.

Cheavens JS, Feldman DB, Gum A, Michael ST, Snyder CR. Hope therapy in a community sample: A pilot investigation. Social Indicators Research 2006; 77(1):61-78.

De Oliveira AD, Vieira AES, Da Silva RC, Neves SJF, Gama TAB, Lima RV, Oliveira WR, Dias JMD. Adverse drug reactions in high-risk pregnant women: A prospective study. Saudi Pharm J 2017; 25(7):1073-7.

Delgado-Mendilivar JM, Cadenas-Diaz JC, Fernandez-Torrico JM, Navarro-Mascarell G, Izquierdo G. A study of the quality of life in cases of multiple sclerosis. Revista de neurologia 2005;41(5):257-62.

Ding XH, Ye P, Wang XN, Cao RH, Yang X, Xiao WK, Zhang Y, Bai YY, Wu HM. Peripheral arterial stiffness is associated with higher baseline plasma uric acid: A prospective cohort study. Saudi Journal of Biological Sciences, 2017; 24(3): 574-581.

Duggleby WD, Degner L, Williams A, Wright K, Cooper D, Popkin D, et al, Living with hope: initial evaluation of a psychosocial hope intervention for older palliative home care patients, J Pain Symptom Manage 2007; 33(3): 247-57.

Fattahi S, Naderi F, Asgari P, Ahadi H. Neuro-Feedback Training For Overweight Women: Improvement of Food Craving And Mental Health. NeuroQuantology. 2017; 15(2).

Fitzner D, Simons M. Chronic progressive multiple sclerosis-pathogenesis of neurodegeneration and therapeutic strategies. Current Neuropharmacology 2010; 8(3):305-15.

Gao W, Wang YQ, Wang WF, Shi L. The first multiplication atom-bond connectivity index of molecular structures in drugs. Saudi Pharmaceutical Journal 2017; 25(4): 548-55.

Ghezelseflo M, Esbati M. Effectiveness of Hope-oriented Group Therapy on Improving Quality of Life in HIV+ Male Patients. Procedia-Social and Behavioral Sciences 2013; 84: 534-7.

Grewal PK, Porter JE. Hope theory: A framework for understanding suicidal action. Death studies. 2007 Feb 1; 31(2):131-54.

Gum A, Snyder CR. Coping with terminal illness: The role of hopeful thinking. Journal of Palliative Medicine 2002; 5(6):883-94.

Harbo HF, Gold R, Tintoré M. Sex and gender issues in multiple sclerosis. Therapeutic Advances in Neurological Disorders 2013; 6(4):237-48.

Hermann BP, Vickrey B, Hays RD, Cramer J, Devinsky O, Meador K, Perrine K, Myers LW, Ellison GW. A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis. Epilepsy Research 1996; 25(2):113-8.

Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A, The multiple sclerosis impact scale (MSIS-29) a new patient-based outcome measure. Brain 2001; 124(5): 962-73.

Janardhan V, Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. Journal of the Neurological Sciences 2002; 205(1):51-8.

Loren A, Rolak MD. Multiple sclerosis: it's not the disease you thought it was. Clinical Medicine and Research 2002; 1(1): 57-60.

Mancia G, Grassi G. Management of essential hypertension. British Medical Bulletin 2010; 94(1):189-99.

McGuigan C, Hutchinson M, The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure, Journal of Neurology Neurosurgery Psychiatry 2004; 75(2): 266-9.

Miller A, Dishon S. Health-related quality of life in multiple sclerosis: the impact of disability, gender and employment status. Quality of life research 2006; 15(2):259-71.

Mitchell AJ, Benito-León J, González JM M, Rivera-Navarro J, Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing, Lancet Neurol 2005; 4(9): 556-66.

Pérez-Cerdá F, Sánchez-Gómez MV, Matute C. The link of inflammation and neurodegeneration in progressive multiple sclerosis. Multiple Sclerosis and Demyelinating Disorders 2016;1(1):9.

Ramp M, Khan F, Misajon RA, Pallant JF, Rasch analysis of the multiple sclerosis impact scale (MSIS-29), Health Qual Life Outcomes 2009; 7(1): 58-68.

Rudick RA, Miller D, Hass S, Hutchinson M, Calabresi PA, Confavreux C, Galetta SL, Giovannoni G, Havrdova E, Kappos L, Lublin FD. Health‐related quality of life in multiple sclerosis: effects of natalizumab. Annals of Neurology 2007; 62(4):335-46.

Rustøen T, Wiklund I, Hanestad BR, Moum T. Nursing intervention to increase hope and quality of life in newly diagnosed cancer patients. Cancer Nursing 1998; 21(4):235-45.

Sanatani M, Schreier G, Stitt L, Level and direction of hope in cancer patients: an exploratory longitudinal study, Support Care Cancer 2008; 16(5): 493-9.

Simmons RD. Life issues in multiple sclerosis. Nature Reviews Neurology 2010; 6(11):603-10.

Snyder CR. Hope theory: Rainbows in the mind. Psychological inquiry 2002;13(4):249-75.

Snyder, C. R., Harris, C., Anderson, J. R., Holleran, S. A., Irving, L. M., Sigmon, S. T., Yoshinobu, L., Gibb, J., Langelle, C., & Harney, P. The will and the ways: development and validation of an individual-differences measure of hope. Journal Personality Social Psychology 1991; 60(4): 570-85.

Snyder CR, Feldman DB, Shorey HS, Rand KL. Hopeful choices: A school counselor's guide to hope theory. Journal of Personality and Social Psychology 2002;65(2002):1061-70.

Snyder CR, Ritschel LA, Rand KL, Berg CJ. Balancing psychological assessments: Including strengths and hope in client reports. Journal of Clinical Psychology 2006; 62(1):33-46.

Tesar N, Baumhackl U, Kopp M, Günther V. Effects of psychological group therapy in patients with multiple sclerosis. Acta Neurologica Scandinavica 2003; 107(6):394-9.

Weis R, Speridakos EC. A meta-analysis of hope enhancement strategies in clinical and community settings. Psychology of well-being: Theory, research and Practice 2011; 1(1):5.


Supporting Agencies





| NeuroScience + QuantumPhysics> NeuroQuantology :: Copyright 2001-2017